ALPK3: A Potential Drug Target in Cell Signaling Pathways (G57538)

Target Name: ALPK3

NCBI ID: G57538

ALPK3

ALPK3: A Potential Drug Target in Cell Signaling Pathways

Alpha-protein kinase 3 (ALPK3) is a protein that plays a critical role in cell signaling pathways. It is a member of the serine/threonine protein kinase family and is involved in a wide range of cellular processes, including cell growth, differentiation, and metabolism. ALPK3 is also a potential drug target and has been identified as a biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

ALPK3 is a protein that is expressed in most tissues and cells in the body. It is a 21-kDa protein that consists of 210 amino acid residues. The protein has a molecular weight of 21.1 kDa and a calculated pI of 6.8. ALPK3 is predominantly expressed in the brain, heart, and pancreas, and is also expressed in other tissues, including muscle, liver, and kidney.

ALPK3 is involved in a wide range of cellular signaling pathways. It is a key regulator of the RAS/MAPK signaling pathway, which is involved in cell growth, differentiation, and survival. The RAS/MAPK signaling pathway is a complex pathway that is involved in the regulation of various cellular processes, including cell signaling, cell division, and cell death. ALPK3 is involved in the regulation of the RAS/MAPK pathway by phosphoorylation and tyrosination of its own protein and the proteins of other cell signaling pathways.

ALPK3 is also involved in the regulation of the PI3K/AKT signaling pathway, which is involved in cell signaling and metabolism. The PI3K/AKT signaling pathway is a signaling pathway that is involved in the regulation of various cellular processes, including cell signaling, cell division, and cell death. ALPK3 is involved in the regulation of the PI3K/AKT pathway by phosphoorylation and tyrosination of its own protein and the proteins of other cell signaling pathways.

In addition to its role in cell signaling pathways, ALPK3 is also involved in the regulation of cellular processes such as cell growth, differentiation, and metabolism. It is a regulator of cell cycle progression, and is involved in the regulation of the G1/S transition, which is a critical step in the cell cycle that is involved in the progression from the G1 phase to the S phase. ALPK3 is also involved in the regulation of cellular metabolism, and is involved in the regulation of various cellular processes, including protein synthesis, DNA replication, and metabolism.

As a potential drug target, ALPK3 is an attractive target for drug development due to its involvement in multiple cellular processes that are involved in the regulation of various diseases. For example, ALPK3 is involved in the regulation of cell signaling pathways, which are involved in the regulation of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Additionally, ALPK3 is involved in the regulation of cellular processes such as cell growth, differentiation, and metabolism, which are also involved in the regulation of various diseases.

In conclusion, ALPK3 is a protein that is involved in a wide range of cellular signaling pathways and plays a critical role in the regulation of various cellular processes in the body. As a potential drug target, ALPK3 is an attractive target for drug development due to its involvement in multiple cellular processes that are involved in the regulation of various diseases. Further research is needed to fully understand the role of ALPK3 in cellular signaling pathways and its potential as a drug target.

Protein Name: Alpha Kinase 3

Functions: Involved in cardiomyocyte differentiation

The "ALPK3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALPK3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets